INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

167 studies · page 1 of 7

2020 / Crossover clinical trial

Extra virgin olive oil reduced inflammatory markers and digestive symptoms in patients with ulcerative colitis

In a crossover clinical trial comparing extra virgin olive oil with canola oil, 32 of 40 patients with ulcerative colitis completed two 20-day intervention rounds. Consumption of extra virgin olive oil was followed by significant decreases in erythrocyte sedimentation rate (p = 0.03) and high-sensitivity C-reactive protein (p < 0.001). Bloating, constipation, fecal urgency, incomplete defecation, and final gastrointestinal symptom rating scale scores were also significantly reduced after extra virgin olive oil consumption (p < 0.05).

NANO counterpoint →

Morvaridi M, Jafarirad S, Seyedian SS, et al. Eur J Clin Nutr, 2020. PMID 31901082

2019 / Randomized controlled trial

Prunes increased stool weight and frequency in healthy adults with low fiber intake.

In a 4-week trial of 120 healthy adults, consuming 80 g/d or 120 g/d of prunes led to significantly greater increases in daily stool weight (+22.2 g/d and +32.8 g/d, respectively) versus control (-0.8 g/d, P = 0.026). Stool frequency was also significantly higher (P = 0.023), with increased Bifidobacteria across groups (P = 0.046) and increased flatulence. Prunes showed no effect on whole gut transit time, short-chain fatty acids, or stool pH.

Lever E, Scott SM, Louis P, et al. Clin Nutr, 2019. PMID 29398337

2019 / Randomized controlled trial

Flixweed and fig improved several constipation-predominant irritable bowel syndrome symptoms.

In a randomized trial, 150 patients with constipation-predominant irritable bowel syndrome consumed flixweed, fig, or control interventions for 4 months. Both flixweed and fig led to significant improvements in pain frequency, distention, defecation frequency, hard stool, quality of life, and bowel habit satisfaction compared to control. Neither intervention significantly altered C-reactive protein concentrations or the intensity of abdominal pain.

Pourmasoumi M, Ghiasvand R, Darvishi L, et al. Explore (NY), 2019. PMID 30318190

2019 / Prospective crossover study

Using a defecation posture modification device reduced straining and bowel movement duration while increasing bowel emptiness.

A prospective crossover study tracked real-time bowel movement data in 52 volunteers over 4 weeks (2 weeks without a defecation postural modification device [DPMD] followed by 2 weeks with DPMD). Across 1119 recorded bowel movements, utilizing the DPMD resulted in increased bowel emptiness (OR 3.64; 95% CI, 2.78-4.77) and reduced straining (OR 0.23; 95% CI, 0.18-0.30). Furthermore, not using the DPMD was associated with increased bowel movement duration (fold increase 1.25; 95% CI, 1.17-1.33).

Modi RM, Hinton A, Pinkhas D, et al. J Clin Gastroenterol, 2019. PMID 30346317

2019 / Clinical trial

Omnivorous diets induce gut microbial pathways that convert dietary l-carnitine into proatherogenic TMAO.

Researchers evaluated isotope-labeled l-carnitine and gamma-butyrobetaine metabolism in 40 omnivores and 32 vegans or vegetarians. Following oral d3-l-carnitine, omnivores generated over 20-fold more d3-TMAO than vegans or vegetarians (P = 0.001), despite comparable fasting plasma carnitine levels. Gut bacteria transformed carnitine into gamma-butyrobetaine in both dietary groups, but conversion of gamma-butyrobetaine to TMA was induced by chronic carnitine intake and omnivorous habits.

Koeth RA, Lam-Galvez BR, Kirsop J, et al. J Clin Invest, 2019. PMID 30530985

2019 / Randomized controlled trial

Diets differing in fat content altered gut bacteria and fecal metabolites

A 6-month feeding trial assigned 217 healthy young adults to lower-fat (20% energy), moderate-fat (30%), or higher-fat (40%) diets. The lower-fat diet was associated with increased alpha-diversity (p = 0.03) and higher abundance of Blautia and Faecalibacterium. Conversely, the higher-fat diet was associated with decreased total short-chain fatty acids (p < 0.001), reduced Faecalibacterium, enriched fecal arachidonic acid, and higher plasma proinflammatory markers.

Wan Y, Wang F, Yuan J, et al. Gut, 2019. PMID 30782617

2019 / Randomized controlled trial

Reducing red and processed meat intake did not lower Crohn's disease relapse rates.

In a randomized trial, 214 adults with Crohn's disease in remission consumed either at least two weekly servings of red or processed meat (n = 118) or maximum one monthly serving (n = 96) for 49 weeks. Symptomatic relapse occurred in 62% of the high-meat participants and 42% of the low-meat cohort. Time to any relapse (P = 0.61) or moderate-to-severe relapse (P = 0.50) did not vary significantly between the dietary arms.

NANO counterpoint →

Albenberg L, Brensinger CM, Wu Q, et al. Gastroenterology, 2019. PMID 30872105

2019 / Single-group trial / case series

Hospitalized ulcerative colitis patients receiving a plant-based diet showed low relapse rates.

A lacto-ovo-semivegetarian regimen was integrated into induction therapy for 92 patients hospitalized with ulcerative colitis. Cumulative relapse rates were 14% at 1 year and 27% at 5 years for initial episode cases, and 36% at 1 year and 53% at 5 years for relapse cases. At a mean follow-up of 6 years and 4 months, adherence measured by the plant-based diet score remained significantly higher than baseline (p < 0.0001).

Chiba M, Nakane K, Tsuji T, et al. Perm J, 2019. PMID 31050638

2019 / Prospective endoscopic challenge study

In patients with IBS, endoscopic challenge with food antigens triggered non-IgE-associated barrier disruption and eosinophil activation in over 50% of cases.

A prospective study challenged 155 patients with IBS using 4 common food components via endoscope followed by confocal laser endomicroscopy (CLE), alongside duodenal biopsy and fluid analysis. Of the 108 patients who completed the study, 76 (70%) had a response to food (CLE+), with 61% of these reacting to wheat. CLE+ patients had significantly higher intraepithelial lymphocytes (P = .001), up-regulated claudin-2 (P = .023), lower occludin levels (P = .022), increased eosinophil degranulation, and higher eosinophilic cationic protein in duodenal fluid (P = .03) compared to controls. Inflammatory cytokine messenger RNA levels remained unchanged after challenge.

Fritscher-Ravens A, Pflaum T, Mösinger M, et al. Gastroenterology, 2019. PMID 31100380

2019 / Pilot study

In patients with metabolic syndrome, blueberry-enriched meals shifted postprandial urinary metabolites and reduced IL-6 while increasing TGF-β expression.

A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.

Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937

2019 / Prospective intervention study with a matched control group

TMAO and its precursors were elevated in PCOS and decreased after 3 months of oral contraceptive use paired with general dietary advice.

Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.

Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132

2018 / Crossover trial

Curcumin reduces intestinal damage and physiological strain during exertional heat stress.

Eight non-heat-acclimated humans ran for 60 minutes in hot conditions after 3 days of 500 mg/day curcumin or placebo. Intestinal fatty acid-binding protein increased less with curcumin (18% to 58%) than placebo (33% to 87%). Placebo triggered significant rises in TNF-α and IL-10 (P < 0.01), whereas curcumin prevented significant changes. Curcumin also lowered the physiological strain index between 40 and 60 minutes of exercise (P < 0.01).

Szymanski MC, Gillum TL, Gould LM, et al. J Appl Physiol (1985), 2018. PMID 28935827

2018 / Randomized crossover trial

Traditional Malian sorghum and millet foods exhibited substantially slower gastric emptying than other staples.

In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.

Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493

2018 / Randomized controlled trial

Vegan fecal microbiota transplants did not lower TMAO production in metabolic syndrome.

Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.

Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220

2018 / Single-group prospective trial

A plant-based diet initiated during a two-week educational hospitalization was followed by low cumulative relapse rates in ulcerative colitis patients.

Sixty patients with mild ulcerative colitis or UC in remission received a plant-based diet (PBD) and dietary guidance during a two-week educational hospitalization. Over a median follow-up of 3 years 6 months, 8 cases relapsed, with cumulative relapse rates at 1, 2, 3, 4, and 5 years of 2%, 4%, 7%, 19%, and 19%, respectively. During hospitalization, 77% of patients experienced improvement such as disappearance or decrease of bloody stool. Both short- and long-term PBD scores remained higher than baseline.

Chiba M, Nakane K, Tsuji T, et al. Perm J, 2018. PMID 30005726

2018 / Prospective single-arm study

A 6-month ketogenic diet reduced gut microbiome alpha diversity and altered bacterial composition in children with refractory epilepsy.

Twenty children with refractory epilepsy were prospectively evaluated before and 6 months after starting a ketogenic diet. Following 6 months of therapy, 2 patients became seizure-free, 3 achieved a ≥ 90% reduction, 5 had a 50-89% reduction, and 10 had a < 50% reduction, with all 10 responders showing EEG improvements. Fecal microbial profiles demonstrated lower alpha diversity compared with baseline, along with significantly decreased Firmicutes and increased Bacteroidetes abundance. Non-responsive patients were found to have enrichment of Clostridiales, Ruminococcaceae, Rikenellaceae, Lachnospiraceae, and Alistipes.

Zhang Y, Zhou S, Zhou Y, et al. Epilepsy Res, 2018. PMID 30007242

2018 / Dietary intervention study

Increased dietary fiber intake was linked to decreased zonulin in fatty liver disease.

In a 6-month dietary intervention among 32 individuals with nonalcoholic fatty liver disease, average daily fiber intake rose from 19 g to 29 g. Serum zonulin dropped by nearly 90% (7.335 vs. 0.507 ng/mL, P = 0.001) and was correlated with fiber intake (P = 0.043) and steatosis grade (P = 0.037). Participants also displayed significant improvements in liver enzymes, triglycerides (P = 0.036), HOMA-IR (P = 0.041), and fatty liver score (P = 0.009).

Krawczyk M, Maciejewska D, Ryterska K, et al. Nutrients, 2018. PMID 30453660

2018 / Non-randomized controlled trial

Gastrointestinal symptoms were more frequent with higher doses of D-allulose in adults

In a non-randomized controlled trial, young adults underwent gastrointestinal tolerance tests with stepwise dose escalations of D-allulose. No severe diarrhea or gastrointestinal symptoms appeared up to 0.4 g/kg body weight, but severe diarrhea occurred at 0.5 g/kg body weight. Compared to sugar, D-allulose was linked to higher frequencies of diarrhea (p = 0.004), abdominal distention (p = 0.039), and abdominal pain (p = 0.031), while escalating total daily intake to 1.0 g/kg body weight produced severe nausea, headache, anorexia, and diarrhea.

Han Y, Choi BR, Kim SY, et al. Nutrients, 2018. PMID 30572580

2017 / Intervention pilot study

Soymilk intake increased fecal bifidobacteria and reduced Enterobacteriaceae in healthy adults.

A pilot study evaluated the effect of soymilk intake on the fecal microbiota and metabolic activities in eight healthy adult humans. During the intake period, the number of bifidobacteria in feces was significantly higher on day 14 compared to baseline (p<0.05), while Enterobacteriaceae counts were significantly lower on days 7 and 14 (p<0.05). At the species or group level, all Bifidobacterium groups studied slightly increased, suggesting soymilk intake may contribute to improving the intestinal environment.

Fujisawa T, Ohashi Y, Shin R, et al. Biosci Microbiota Food Health, 2017. PMID 28243549

2017 / Randomized controlled trial

A ketogenic diet reduced seizure frequency and severity in pediatric intractable epilepsy compared to usual care, but cost per QALY was inconclusive.

Children and adolescents with intractable epilepsy were randomized to a ketogenic diet (KD) or care as usual (CAU) and followed for 16 months. In total, 58% of the KD group completed follow-up (11 dropped out). At 16 months, 35% of KD participants achieved a seizure reduction of ≥50% from baseline versus 18% in the CAU group, and 46.2% reported decreased worst seizure severity versus 32% in CAU. Mean per-patient costs were €61,019 in the KD group compared with €53,367 (extrapolated) in CAU, giving an ICER of €46,564 per responder. The KD group had significantly more gastrointestinal issues at 4 months but fewer at 16 months compared to CAU; cost per QALY ratios were inconclusive due to minimal QALY differences.

Wijnen BFM, de Kinderen RJA, Lambrechts DAJE, et al. Epilepsy Res, 2017. PMID 28364726

2017 / Randomized controlled trial

High-fiber dietary advice reduced gastrointestinal toxicity during and after pelvic radiotherapy.

In a randomized trial, 166 patients receiving pelvic radiotherapy were assigned to low-fiber, habitual-fiber, or high-fiber dietary counseling. Although the primary endpoint of start-to-nadir bowel score changes did not differ significantly between groups (P = 0.093), high-fiber advice led to smaller score reductions from start to end of radiotherapy (-3.7 ± 12.8 vs -10.8 ± 13.5; P = 0.011). At 1 year, the high-fiber group maintained significantly better bowel scores than the habitual-fiber group (+0.1 ± 14.5 vs -8.4 ± 13.3; P = 0.004).

Wedlake L, Shaw C, McNair H, et al. Am J Clin Nutr, 2017. PMID 28679552

2017 / Prospective single-group trial

Infliximab combined with a plant-based diet induced high remission rates at 6 weeks in biologic-naïve patients with Crohn disease.

Biologic-naïve patients with Crohn disease received standard infliximab induction along with a lacto-ovo-semivegetarian diet during hospitalization. Two adults were withdrawn due to intestinal obstruction. Intention-to-treat and per-protocol remission rates at week 6 were 96% (44/46) and 100% (44/44), respectively. Mean CDAI score dropped from 314 on admission to 63 at week 6 (p < 0.0001), mean CRP decreased from 5.3 mg/dL to 0.2 mg/dL (p < 0.0001), and mucosal healing was achieved in 46% (19/41) of cases.

Chiba M, Tsuji T, Nakane K, et al. Perm J, 2017. PMID 29035182

2016 / Prospective comparative effectiveness trial

Eliminating cow's milk led to significant histologic and symptomatic improvement comparable to swallowed fluticasone in pediatric eosinophilic esophagitis.

A prospective comparative effectiveness trial compared cow's milk elimination (n = 20) with swallowed fluticasone (n = 24) in newly diagnosed pediatric patients with eosinophilic esophagitis (EoE). After 6-8 weeks, peak esophageal eosinophil counts dropped below 15 eosinophils/high-power field in 64% of the cow's milk elimination group and 80% of the fluticasone group (P = 0.4). In the milk elimination group, mean PedsQL EoE Module total scores improved from 69 to 82 (P < 0.005) and Total Symptoms scores improved from 58 to 75 (P = 0.001). For swallowed fluticasone, scores also significantly improved (Module: 64 to 75, P < 0.05; Symptoms: 58 to 69, P < 0.01).

Kruszewski PG, Russo JM, Franciosi JP, et al. Dis Esophagus, 2016. PMID 25721813

2016 / Prospective single-group study

"The Thinker" defecation position showed wider anorectal angles and allowed complete evacuation in 11 of 22 patients unable to evacuate while sitting.

Researchers evaluated the effect of 'The Thinker' posture (bending the upper body) on defecation using cinedefecography in 22 patients unable to evacuate barium paste while normally seated. During straining, 'The Thinker' position resulted in a significantly wider ARA (134° vs. 113°, p = 0.03), larger PPD (9.3 vs. 7.1 cm, p = 0.02), and longer PRL (15.2 vs. 12.9 cm, p = 0.005) compared with the sitting position. Additionally, 11 of the 22 patients were able to evacuate completely in 'The Thinker' position.

Takano S, Sands DR Tech Coloproctol, 2016. PMID 26690926